Nature genetics · 2018
Individual variations in cardiovascular-disease-related protein levels are driven by genetics and gut microbiome.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhernakova Daria V, Le Trang H, Kurilshikov Alexander, Atanasovska Biljana, Bonder Marc Jan, Sanna Serena, Claringbould Annique, Võsa Urmo, Deelen Patrick, Franke Lude, de Boer Rudolf A, Kuipers Folkert, Netea Mihai G, Hofker Marten H, Wijmenga Cisca, Zhernakova Alexandra, Fu Jingyuan, LifeLines cohort study, BIOS consortium
Аннотация
Despite a growing body of evidence, the role of the gut microbiome in cardiovascular diseases is still unclear. Here, we present a systems-genome-wide and metagenome-wide association study on plasma concentrations of 92 cardiovascular-disease-related proteins in the population cohort LifeLines-DEEP. We identified genetic components for 73 proteins and microbial associations for 41 proteins, of which 31 were associated to both. The genetic and microbial factors identified mostly exert additive effects and collectively explain up to 76.6% of inter-individual variation (17.5% on average). Genetics contribute most to concentrations of immune-related proteins, while the gut microbiome contributes most to proteins involved in metabolism and intestinal health. We found several host-microbe interactions that impact proteins involved in epithelial function, lipid metabolism, and central nervous system function. This study provides important evidence for a joint genetic and microbial effect in cardiovascular disease and provides directions for future applications in personalized medicine.